openPR Logo
Press release

Cardiac Surgery Devices Market Set for Robust Growth to US$ 2.6 Billion by 2032

10-27-2025 06:20 AM CET | Health & Medicine

Press release from: DataM Intelligence

Cardiac Surgery Devices Market

Cardiac Surgery Devices Market

The global cardiac surgery devices market continues its upward trajectory, with DataM Intelligence projecting a rise from US$ 2.0 billion in 2025 to US$ 2.6 billion by 2032. This expansion, at a CAGR of 3.9%, is driven by the increasing global prevalence of cardiovascular diseases, especially among aging and urban populations. The adoption of minimally invasive techniques, advancements in AI and robotics, and strong demand for devices such as heart valves and cardiopulmonary bypass machines are transforming surgical precision and patient outcomes, positioning the market as highly competitive and innovation-centric.

Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/cardiac-surgery-devices-market?utm_source=OpenPR&utm_campaign=Onkar

Key Highlights from the Report

➤ Cardiac surgery devices market expected to reach US$ 2.6 billion by 2032.

➤ Rising incidence of global heart diseases propels market growth.

➤ AI, robotics, and 3D printing enhance surgical precision and patient outcomes.

➤ Cardiopulmonary bypass machines and artificial heart valves remain in strong demand.

➤ Mergers, partnerships, and acquisitions expand company portfolios and market reach.

➤ North America leads the market, supported by advanced healthcare infrastructure and R&D spending.

Market Segmentation

The cardiac surgery devices market is segmented by product, procedure, and end-user categories. Cardiopulmonary bypass (CPB) systems are a leading product, as they are indispensable for open-heart surgeries like coronary artery bypass grafting (CABG) and valve repairs. These machines, along with artificial valves and advanced monitoring tools, see consistent demand from hospitals due to the high volume of cardiac procedures and reusable equipment requirements. Procedure-wise, coronary surgeries-especially CABG-drive market growth owing to the widespread prevalence of coronary artery disease. Hospitals dominate the end-user segment, leveraging advanced technologies and skilled professionals to offer top-tier cardiac care, thereby supporting continuous market expansion.

Get Customization in the Report as Per Your Business Requirements: https://www.datamintelligence.com/customize/cardiac-surgery-devices-market?utm_source=OpenPR&utm_campaign=Onkar

Regional Insights

North America dominates the cardiac surgery devices market, led by the United States' advanced healthcare infrastructure, high R&D spending, strong regulatory framework, and presence of leading device manufacturers. Cutting-edge hospitals and cardiovascular centers further advance the adoption of innovative cardiac devices. Europe maintains its position as a hub for device innovation and research, driven by growing adoption of minimally invasive and robotic surgeries, favorable reimbursement models, and robust EU-funded healthcare research. Asia Pacific sees rising demand, with China, India, and Japan experiencing high rates of heart disease and rapid improvements in healthcare investment and access. Landmark medical innovations, such as magnetically levitated biventricular assist devices for pediatric patients, highlight the region's commitment to advanced cardiac care.

Market Dynamics

Market Drivers

Increasing global prevalence of cardiovascular diseases and aging populations fundamentally drive cardiac device adoption. Hospitals and clinics are investing in advanced heart valves, bypass machines, and AI-integrated systems to enhance patient outcomes and manage surging demand.

Market Restraints

Risks such as device recalls and associated legal liabilities pose challenges. Regulatory scrutiny and product safety incidents can lead to costly recalls, temporary bans, and stricter compliance, affecting manufacturer profitability and pacing innovation, as seen in recent Medtronic cannula recall cases.

Market Opportunities

Artificial intelligence enables predictive and personalized cardiac surgeries, analyzing patient data and surgical risks in real time. AI-driven decision support and robotics promise enhanced precision, improved recovery rates, and expanded access to advanced procedures, especially in emerging economies.

Purchase This Exclusive Report at Just USD 4874 Only: https://www.datamintelligence.com/buy-now-page?report=cardiac-surgery-devices-market?utm_source=OpenPR&utm_campaign=Onkar

Reasons to Buy the Report

✔ Analyze global market growth and emerging trends in cardiac devices
✔ Evaluate technological advancements in AI, robotics, and minimally invasive surgery
✔ Gain insights into competitive landscape, mergers, and strategic partnerships
✔ Learn about regulatory developments, device approvals, and safety standards
✔ Access comprehensive regional analysis for strategic investment decisions

Frequently Asked Questions (FAQs)

◆ How big is the global cardiac surgery devices market?
◆ Who are the Key Players in the Cardiac Surgery Devices Market?
◆ What is the projected growth rate of the cardiac surgery devices market?
◆ What is the market forecast for 2032?
◆ Which region is estimated to dominate the global industry through the forecast period?

Company Insights

Abbott Laboratories

Medtronic Plc.

Boston Scientific Corporation

Johnson & Johnson (Ethicon)

B. Braun Melsungen AG

Terumo Corporation

LivaNova PLC

Edwards Lifesciences Corporation

Cardinal Health

Stryker Corporation

Cook Medical

Philips Healthcare

Getinge Group

Hologic, Inc.

AtriCure, Inc.

Lepu Medical Technology Co. Ltd.

C.R. Bard (BD)

Zoll Medical Corporation

Merit Medical Systems, Inc.

Asahi Intecc Co., Ltd.

Others

Recent Developments:

In January 2025, Boston Scientific Corporation acquired Bolt Medical, Inc., enhancing its laser-based platform for coronary and peripheral artery disease treatment.

In April 2024, Abbott Laboratories received U.S. FDA approval for a new heart valve repair device, closely following Edwards Lifesciences' approval for a rival device.

Conclusion

The cardiac surgery devices market is poised for steady expansion, driven by epidemiological trends, relentless technological innovation, and growing worldwide adoption of advanced surgical solutions. As healthcare systems and manufacturers prioritize patient outcomes, affordability, and accessibility, the industry is expected to deliver life-saving advances, continuous improvement in surgical safety, and strong opportunities for stakeholders through 2032.

Contact Us

Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Visit Our Website: https://www.datamintelligence.com

About Us

DataM Intelligence 4Market Research is a comprehensive market intelligence platform offering syndicated and customized reports along with expert consulting across multiple industries, including chemicals, healthcare, agriculture, food & beverages, and more. With extensive experience and a strategy-focused approach, DataM provides businesses and individuals with reliable market insights, statistical forecasts, and personalized research solutions to help them make informed decisions and successfully bring innovations to market.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Surgery Devices Market Set for Robust Growth to US$ 2.6 Billion by 2032 here

News-ID: 4239616 • Views:

More Releases from DataM Intelligence

U.S. Radiopharmaceuticals Market to Reach USD 2.36 Billion by 2033, Growing at 6.3% CAGR Driven by Advances in Nuclear Medicine and Theranostics
U.S. Radiopharmaceuticals Market to Reach USD 2.36 Billion by 2033, Growing at 6 …
The United States radiopharmaceuticals market was valued at USD 2.21 billion in 2024 and is projected to reach USD 2.36 billion by 2033, exhibiting a CAGR of 6.3% during the forecast period, according to DataM Intelligence. The market expansion is primarily fueled by the growing prevalence of chronic diseases such as cancer and cardiovascular disorders, advancements in diagnostic imaging, and regulatory support for nuclear medicine infrastructure. Radiopharmaceuticals play a pivotal
U.S. Food Flavors Market to Reach USD 6.1 Billion by 2033, Registering 5.2% CAGR Driven by Demand for Natural and Innovative Taste Solutions
U.S. Food Flavors Market to Reach USD 6.1 Billion by 2033, Registering 5.2% CAGR …
The U.S. flavors market was valued at USD 3,887.7 million in 2024 and is projected to reach USD 6,108.4 million by 2033, growing at a CAGR of 5.2% during 2025-2033, according to DataM Intelligence. The market's growth is driven by surging demand for processed foods, global flavor innovation, and increasing consumer preference for natural, clean-label, and wellness-oriented products. Flavors continue to play a vital role in enhancing the sensory experience
Europe Feed Premix Market to Reach USD 7.31 Billion by 2030, Growing at a 4.32% CAGR Amid Rising Animal Nutrition Investments
Europe Feed Premix Market to Reach USD 7.31 Billion by 2030, Growing at a 4.32% …
The Europe Feed Premix Market is estimated to grow from USD 5.92 billion in 2025 to USD 7.31 billion by 2030, registering a CAGR of 4.32% during the forecast period, according to DataM Intelligence. The market's growth is driven by increasing demand for nutrient-rich animal feed formulations, expanding livestock production, and a rising preference for high-quality, antibiotic-free animal products. Feed premixes-comprising essential vitamins, minerals, amino acids, and other additives-are vital
North America Feed Phytogenics Market to Reach USD 500.6 Million by 2030, Growing at a 5.5% CAGR on Rising Demand for Natural Additives
North America Feed Phytogenics Market to Reach USD 500.6 Million by 2030, Growin …
The North America Feed Phytogenics Market is projected to grow from USD 383.10 million in 2025 to USD 500.60 million by 2030, at a CAGR of 5.5% during the forecast period, according to DataM Intelligence. The market is witnessing robust growth due to rising demand for high-quality animal-derived products and increasing regulatory restrictions on antibiotics in livestock production. As a result, plant-based feed solutions have gained widespread adoption for improving

All 5 Releases


More Releases for Cardiac

Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise. Request
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiac Monitoring & Cardiac Rhythm Management Devices
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest. Browse 145 Market Data Tables and 119 Figures spread
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,